Key Players Shaping the Therapeutic Nuclear Medicines Market By 2022 to 2028

 

The global therapeutic nuclear medicines market is poised for remarkable growth, with projections indicating a surge from a valuation of US$ 1 billion in 2022 to an impressive US$ 1.84 billion by 2028. This trajectory represents a robust Compound Annual Growth Rate (CAGR) of 10.6%.

Therapeutic nuclear medicines constitute a rapidly expanding segment within the broader nuclear medicine field, playing a pivotal role in the diagnosis and treatment of various medical conditions. This specialized sector revolves around radiopharmaceuticals, which are radioactive chemicals utilized for therapeutic purposes. These innovative drugs empower medical professionals to precisely target and treat specific disease areas within the body, such as tumors or hyperactive thyroid glands, through intravenous or oral administration.

To Get The Sample Copy Of Report Visit! https://www.futuremarketinsights.com/reports/sample/rep-gb-2930

One of the standout advantages of therapeutic nuclear medicines lies in their capacity to deliver targeted and localized therapies while minimizing harm to surrounding healthy tissues. By leveraging radiation therapy with pinpoint accuracy, these medicines maximize the likelihood of positive treatment outcomes while mitigating adverse side effects. Notably, therapeutic nuclear medicines extend their efficacy beyond addressing cancer-related bone pain and hyperthyroidism, encompassing a spectrum of other medical conditions.

"This projected growth underscores the increasing significance of therapeutic nuclear medicines in modern healthcare," remarked Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.). "The precision and efficacy offered by these advanced treatments are reshaping the landscape of medical care, promising new avenues for combating a wide array of ailments."

As the demand for targeted and minimally invasive medical interventions continues to soar, the therapeutic nuclear medicines market stands poised for substantial expansion, driving innovations that hold the potential to revolutionize patient care worldwide.

Key points about the therapeutic nuclear medicines market include:

  • Radiopharmaceuticals: Radiopharmaceuticals used in therapeutic nuclear medicine are typically made up of a radioactive isotope (e.g., iodine-131, lutetium-177, yttrium-90) combined with a carrier molecule that helps target specific cells or tissues. These radiopharmaceuticals are administered to patients either orally or intravenously.
  • Cancer Treatment: One of the most significant applications of therapeutic nuclear medicine is in the treatment of cancer. Radiopharmaceuticals can be used to deliver targeted radiation therapy to cancerous cells, minimizing damage to surrounding healthy tissues.
  • Hyperthyroidism Treatment: Radioactive iodine-131 is commonly used to treat hyperthyroidism by selectively destroying overactive thyroid tissue.
  • Bone Metastases: Radiopharmaceuticals like strontium-89 and samarium-153 are used to treat bone metastases, providing pain relief and reducing bone-related complications in cancer patients.
  • Growing Market: The therapeutic nuclear medicines market has been experiencing growth due to advances in radiopharmaceutical development, increased adoption of targeted therapies, and a growing prevalence of diseases such as cancer. The market is also benefiting from improved imaging and diagnostic techniques.
  • Regulatory Oversight: The use of radioactive materials in medicine is tightly regulated by health authorities in various countries to ensure patient safety and minimize radiation exposure. Radiopharmaceutical production facilities and healthcare institutions that use these therapies must adhere to strict quality and safety standards.

Key Companies Profiled:

  • Bayer AG
  • GE Healthcare
  • Novartis AG
  • Cardinal Health Inc.
  • Mallinckrodt plc.
  • Lantheus Medical Imaging Inc.
  • Bracco Imaging S.p.A
  • Eckert & Ziegler
  • Curium Pharma
  • International Isotopes Idaho, Inc.
  • Medi-Radiopharma Co., Ltd.

Key Segments of Therapeutic Nuclear Medicines Industry Survey:

Therapeutic Nuclear Medicines Market by Treatment:

  • Radium-223
  • Iodine-131
  • Leutitium-177
  • Yttrium-90
  • Samarium-153
  • Strontium-89
  • Rhenium-188+Rhenium-186
  • Erbium- 169
  • Phosphorous-32
  • Others

Therapeutic Nuclear Medicines Market by Indication:

  • Prostate Cancer
  • Painful Bone Metastases
  • Thyroid Cancer
  • Neuroblastoma
  • Synovitis
  • Non-Hodgkin’s Lymphoma
  • Hepatic Metastases
  • Brain Tumour
  • Others

Therapeutic Nuclear Medicines Market by Distribution Channel:

  • Hospitals
  • Ambulatory Surgical Centers
  • Cancer Research Institutes

Therapeutic Nuclear Medicines Market by Region:

  • North America Therapeutic Nuclear Medicines Market
  • Latin America Therapeutic Nuclear Medicines Market
  • Europe Therapeutic Nuclear Medicines Market
  • East Asia Therapeutic Nuclear Medicines Market
  • South Asia & Pacific Therapeutic Nuclear Medicines Market
  • Middle East & Africa (MEA) Therapeutic Nuclear Medicines Market

Comments

Post a Comment

Popular posts from this blog

Teleradiology Services Market Analysis And Demand With Forecast Overview To 2032

Image
 In 2022, it is expected that the Teleradiology Services Market would be worth around US$ 31,880.57 Million. By 2032, it is anticipated that the market for teleradiology services would reach US$5,598.3 Million. with a 19% CAGR growth forecast through 2032. The global Teleradiology Services Market is estimated to reach a market valuation of US$ 1,971.4 Million by the end of 2016 and register a CAGR of 21.0% over the forecast period (2016–2026). The growth of this market can be attributed to the favorable government initiatives regarding the adoption of teleradiology in order to provide early disease diagnosis. Besides, the application of modern-day technologies such as the adoption of cloud-based technologies, blockchain, and cryptocurrencies will lead to better efficiency and cost-effective solutions. Increasing Investments for the development of advanced solutions is augmenting the demand for the industry. Request Sample PDF Brochure: https://www.futuremarketinsights.com/reports/...
Read more

Non-Vascular Stents Market to 2032 – Global Analysis and Forecasts by Types, Technologies, Applications and End-User Verticals

Image
 The Non-Vascular Stents Market is expected to grow at a CAGR of  4.5%  over the forecast period. (2022 - 2032). The sector is expected to be valued at  US$ 1.21 billion  in 2022 and  US$ 1.9 billion by 2032. The global non-vascular stents market is expected to move forward in response to the growing demand for minimally-invasive procedures. Rising technological and material advancements are assisting in the development of specially designed stents for use in a variety of indications thereby fueling the overall non-vascular stents market growth. Non-vascular stents use small, precise incisions, resulting in scars that are smaller and less visible than those left by traditional surgical techniques, putting the patient's safety in jeopardy. The above-mentioned feature is anticipated to provide impetus to the non-vascular stents market adoption trends in coming years. Such a surgery is associated with a faster recovery period, resulting in a shorter hospital ...
Read more

From X-rays to AI: Veterinary Imaging Innovations of the Next Decade By 2022 to 2030

Image
  Between 2022 and 2030, the global veterinary imaging industry is expected to grow at a CAGR of 6.6%, from US$ 2.02 billion in 2022 to US$ 3.37 billion by 2030. A study by Future Industry Insights (FMI) predicted that by 2030, the worldwide veterinary imaging industry would bring in US$ 3.37 billion. The research study looks at the market development for veterinary imaging through 2030 in more than 20 nations. The report offers precise insights into some of the key players in the industry's crucial business strategies. According to the poll, investments are being made in the veterinary diagnostics industry as the trend towards pet humanization picks up speed. Additionally likely to fuel industry growth are governmental rules and a greater emphasis on preserving animal health. Request A Report Sample To Gain Comprehensive Insights! https://www.futuremarketinsights.com/reports/sample/rep-gb-12368 Growth will also be fueled by the expansion of the animal and pet care industry as a w...
Read more